![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 36, 25623-25631, September 3, 1999
,
,
¶
From the
Glycobiology Research and Training Center,
Divisions of Hematology-Oncology and Cellular and Molecular Medicine,
University of California San Diego, La Jolla, California 92093 and the
§ Ontario Cancer Institute, University of Toronto,
Ontario M5G 2M9, Canada
| |
ABSTRACT |
|---|
|
|
|---|
9-O-Acetylation is one of the most
common modifications of sialic acids, and it can affect several sialic
acid-mediated recognition phenomena. We previously reported a cDNA
encoding a lysosomal sialic acid-specific
9-O-acetylesterase, which traverses the endoplasmic reticulum-Golgi pathway and localizes primarily to lysosomes and endosomes. In this study, we report a variant cDNA derived from the
same gene that contains a different 5' region. This cDNA has a
putative open reading frame lacking a signal peptide-encoding sequence
and is thus a candidate for the previously described cytosolic sialic
acid 9-O-acetylesterase activity. Epitope-tagged constructs
confirm that the new sequence causes the protein product to be targeted
to the cytosol and has esterase activity. Using reverse
transcription-polymerase chain reaction to distinguish the two forms of
message, we show that although the lysosomal sialic acid-specific
9-O-acetylesterase message has a widespread pattern of
expression in adult mouse tissues, this cytosolic sialic acid
9-O-acetylesterase form has a rather restricted
distribution, with the strongest expression in the liver, ovary, and
brain. Using a polyclonal antibody directed against the 69-amino acid region common to both proteins, we confirmed that the expression of
glycosylated and nonglycosylated polypeptides occurred in appropriate subcellular fractions of normal mouse tissues. Rodent liver
polypeptides reacting to the antibody also co-purify with previously
described lysosomal sialic acid esterase activity and at least a
portion of the cytosolic activity. Thus, two sialic acid
9-O-acetylesterases found in very different subcellular
compartments can be encoded by a single gene by differential usage of a
signal peptide-encoding exon at the N terminus. The 5'-rapid
amplification of cDNA ends results and the differences in
tissue-specific expression suggest that expression of these two
products may be differentially regulated by independent promoters.
Sialic acids (Sias)1 are
a diverse family of acidic 9-carbon sugars typically found at the
nonreducing end of sugar chains of animals throughout the deuterostome
lineage (1, 2). Sias are now recognized not only as molecules
responsible for negative charge and hydrophilicity of the cell surface
but also as specific ligands playing important roles in intercellular
and/or intermolecular recognition phenomena (3). There have been
several vertebrate receptors reported for Sia-containing determinants,
including the selectin family (4-6) and the Siglec family (7-10).
Sias are also known to be targets for a variety of microbial proteins involved in host cell recognition, e.g. the influenza virus
hemagglutinin (11) and one of the adhesins of Helicobacter
pylori (12-14).
The Sia molecule can be modified by the addition of O-acetyl
esters on the hydroxyl-groups of the 4, 7, 8, and 9 positions (2). This
O-acetylation of Sia is a common modification found in
mammalian cell surface sialoglycoconjugates and can also be present on
free Sias in the cytosol (15, 16). One example of a well characterized
O-acetylated sialoglycoconjugate is
9(7)-O-acetylated-GD3 and structurally related
disialogangliosides, which show developmentally regulated expression
and gradient patterns for its staining with monospecific antibodies in
the developing brain (17, 18). Specific antibodies showed that the
expression of 9-O-acetylated GD3 appears to be
independently regulated from that of the parental molecule,
GD3 (18), and occurs on the migrating neural cells (19).
Despite the widespread and regulated occurrence of this modification,
the biological significance of O-acetylation is largely unknown. It has been shown that O-acetylation of Sia can
mask the Sia-containing determinant from recognizing its counter
receptor lectin Siglec-2 (CD22) (20). Direct or indirect evidence
indicates that binding of other members of the Siglec family to their
sialylated ligands can also be blocked by O-acetylation
(21-25). In contrast, influenza virus C hemagglutinin specifically
requires 9-O-acetylated Sia for binding to host cells (11,
26). These examples indicate that O-acetylation may be a key
modification regulating Sia-dependent recognition
events. In fact, cleavage of 9-O-acetyl groups from Sia molecules by transgenic expression of influenza C virus
hemagglutinin 9-O-acetylesterase caused abnormalities in
murine development (27).
The biosynthesis of O-acetylated sialoglycoconjugates is
catalyzed by Sia-specific O-acetyltransferase(s) that use
acetyl-CoA as an acetyl donor (28). This O-acetylation
reaction appears to take place in the late Golgi apparatus, after the
action of sialyltransferases (29). Various lines of evidence indicate the existence of a family of 9(7)-O-acetyltransferase(s)
that are linkage- and molecule -specific in their action, likely
explaining the tissue- and stage-specific expression of this
modification (30). These labile Golgi enzymes have so far proven
refractory to purification or cloning. This modification can be removed
by Sia-specific 9-O-acetylesterases. We and others have
previously described two distinct forms of mammalian Sia
O-acetylesterases, one in the cytosolic fraction and
another in the lysosomal/endosomal compartment (31-34). This
localization of the lysosomal Sia 9-O-acetylesterase (Lse)
is somewhat unusual, considering its neutral pH optimum (34).
Regardless, this enzyme is likely to be the one participating in the
terminal lysosomal degradation of 9-O-acetylated
sialoglycoconjugates. However, it would not have access to free
9-O-acetylated Sias that have been reported in the cytosolic
fraction. These presumably result from the action of lysosomal
sialidases on 9-O-acetylated Sias, followed by export of
such molecules to the cytosol by the action of the lysosomal Sia
exporter (15, 16). Such 9-O-acetylated Sias entering the
cytosol are known to be poor substrates for reactivation by CMP-Sia
synthase (35), and CMP-9-O-acetylated Sias in turn are poor
substrates for some sialyltransferases (35). Thus, we have suggested
that the function of the cytosolic Sia 9-O-acetylesterase
(Cse) activity is to salvage any 9-O-acetylated molecules
that escape the initial action of the Lse enzyme.
The Cse and Lse enzyme activities are both found in the
ultracentrifugate supernatant of freeze-thawed rat liver (the soluble Lse enzyme is presumably released by the breakage of lysosomal membranes during freeze-thaw) or in detergent extracts. The two activities can be biochemically separated by ConA-Sepharose
chromatography (the Lse binds and the Cse runs through the column)
and/or by DEAE-cellulose chromatography (the Cse binds and the Lse runs through) (36). Furthermore, the reported properties of the Cse are
somewhat different from that of the Lse (32, 37). Finally, some
antibodies directed against the Lse did not seem to precipitate the Cse
activity (33). Based on all of these criteria, it has always been
assumed that the Lse and Cse enzymes are products of separate genes.
We earlier purified the Lse to homogeneity and obtained N-terminal
amino acid sequences of the two subunits (33). These sequences were
subsequently used to identify the Lse cDNA, which was initially
isolated serendipitously during differential display analysis of
different stages of murine hematopoietic development (38). The cDNA
encoding the Lse was also independently cloned by means of differential
display comparisons between different stages of the murine B lymphoid
cell lineage (39). During the characterization of the latter system,
several cDNAs were noted to have 5' sequences that were different
from the originally isolated Lse form. Here we report the
characterization of one of these cDNAs and show that it can encode
a cytosolic counterpart of the Lse.
Materials--
All reagents used for this study were of
appropriate grade for either biochemistry or molecular biology and
unless otherwise stated were obtained from Sigma. Unless otherwise
stated, typical experiments followed the Current Protocols in
Molecular Biology (40), Current Protocols in Protein
Science (41), or Molecular Cloning (42).
FLAG-tagged cDNA Constructs for the Transfection into COS7
Cells--
7A3-C is a cDNA clone previously isolated from the
70Z/3 pre B-cell line cDNA library by cross-hybridization to the
Lse (39). We subcloned the Lse into the expression vector
pcDNAI/Amp (Invitrogen) after PCR-derived mutagenesis to add a FLAG
epitope in its C terminus (Lse-FLAG) as reported previously (38). We
then exchanged the 5' region of Lse from the 7A3-C using the
BalI site within the coding sequence of both forms and
HindIII site in the multiple cloning site of pcDNAI/Amp
(giving Cse-C-FLAG). Plasmid DNA was prepared using a Qiagen
maxi-column (Qiagen) and transiently transfected into COS cells using
LipofectAMINE (Life Technologies, Inc.), according to the
manufacturer's instructions. Briefly, 20 µg of plasmid DNA is
premixed with 80 µl of LipofectAMINE reagent, and this mixture
was used to transfect COS7 cells 18 h after the subculture into 10 each of 140-mm dishes. At the time of transfection, the cell density
was ~25-30% confluent. After the transfection procedure in Opti-MEM
for 5 h, Western Blotting Analysis of Cse-C Transiently Expressed in COS7
Cells--
Transfected cells were washed with phosphate-buffered
saline, scraped off from the dish, washed twice with phosphate-buffered saline, and homogenized in 25 mM Tris-HCl, pH 7.3, containing 1 mM dithiothreitol using gentle sonication. The
homogenate was centrifuged 500 × g for 5 min, and the
post-nuclear supernatant was then ultracentrifuged at 100,000 × g for 40 min. The resulting supernatant was then incubated
with anti-FLAG M2-Sepharose (Eastman-Kodak) resin overnight at 4 °C
with rotation. The M2 resin was packed into a mini-column and eluted
with 100 mM glycine-HCl, pH 3.0. The eluted fractions were
neutralized immediately by adding drops of 1 M Tris-HCl, pH
8.5, and aliquots of each were subjected to 12.5% SDS-PAGE in either
reduced or nonreduced conditions. Gels were then electrotransferred to
nitrocellulose membranes (Bio-Rad) in a wet condition and blocked in
2% dry milk in Tris-buffered saline with 0.2% Tween. The blot was
exposed to the primary anti-FLAG antibody M2 (1:2500 in Tris-buffered
saline) for 1 h followed by washing and exposure to the secondary
goat anti-mouse IgG horseradish peroxidase (Bio-Rad) for 1 h.
Membranes were washed for more than 1 h. Horseradish peroxidase
activity was then developed using the Supersignal substrate (Pierce)
for 5 min. The signal was visualized by detection of chemiluminescence
using x-ray film (Kodak) for periods ranging from a few seconds to 10 min.
Indirect Immunofluorescent Staining of Transiently Transfected
COS7 Cells--
COS7 cells were transfected with FLAG-tagged
constructs in 8-well chamber slides as described above. After overnight
culture, cells were fixed with ice-cold acetone:methanol 1:1 and
subjected to staining (the signal following 2 days of culture was too
strong for the analysis). Briefly, fixed cells were washed with
phosphate-buffered saline, incubated with 10 µg/ml of anti-FLAG
antibody M2 (Eastman-Kodak) for 30 min at room temperature. Unbound
antibody was washed off, and the cells were incubated with 1 µg/ml of
fluorescein isothiocyanate-conjugated goat anti-mouse IgG for 30 min at
room temperature. Unbound antibody was again washed off, and the slides
were coverslipped using 9:1 glycerol/phosphate-buffered saline for
viewing with a Zeiss Axiophot epifluoresence microscope. Images were
captured using Adobe Photoshop software with a Sony CCD camera.
RT-PCR Analysis of Two Forms of cDNA--
Total cellular RNA
was purified from various tissues of C57Bl/6 strain mice using Trizol
reagent (Life Technologies, Inc.). Total RNA (20 µg) was reverse
transcribed by superscript II (Life Technologies, Inc.) in a 20-µl
reaction. 2.5 µl of first strand cDNA was used for PCR with 30 cycles for Lse amplification and 40 cycles for Cse-C amplification
(preincubation at 94 °C for 2 min, 94 °C for 0.5 min, 60 °C
for 1 min, and 72 °C for 2 min) using a Gene Amp 2400 (Perkin-Elmer). Primer sequences for the amplification were carried out
using Lse-1 (anneals specific to Lse cDNA) versus Lse-J
(should anneal to both forms) for Lse amplification and Cse-11 (anneals
specific to Cse-C cDNA) versus Lse-J for Cse-C amplification. Sequence and position of these primers are as follows, Lse-1 (sense primer for Lse corresponding to positions cDNA 2-23) 5'-atcaggatcttcacaaacatggt-3', Lse-J (antisense primer for Lse/Cse-C corresponding to Lse cDNA positions 816-795) and
5'-gaaacctctcttctggacaag-3', and Cse-11 (sense primer for Cse-C
corresponding to cDNA positions 124-144)
5'-aaaggacatgaggactcctcac-3'. Predicted amplified fragments were 810 bp
for Lse and 890 bp for Cse-C (more than one band including 890 bp was
actually seen for the latter). RT-PCR products were then directly
sequenced or subcloned into a TA-cloning vector pCR II (Invitrogen),
and multiple clones were sequenced by the cycle dideoxy termination
sequencing method with an ABI model 310 autosequencer using M13-20
forward or reverse primers as primers. Not all the bands shown in
agarose gel were recovered after gel purification, possibly because
some are actually heterogenously annealed DNAs of different size.
Production of a Chicken Anti-serum Directed against the Common
Esterase C Terminus--
We had previously found that rabbits produced
very low titer antibodies against intact Lse (33). We therefore decided
to raise antibodies against a defined peptide region in chickens. The
69-amino acid portion shared by Lse and Cse-C cDNAs (see Fig. 1B) was amplified using Pwo polymerase (Boehringer Mannheim)
and the product subcloned into pMAL-p2 vector (New England Biolabs) as
an in-frame maltose-binding protein fusion protein. The fusion protein
was induced in LB containing 0.3 mM isopropyl
1-thio- Preparation and Fractionation of a High Speed Supernatant from
Mouse Liver--
Mouse (C57Bl/6) liver was subjected to three cycles
of freeze and thaw in hypotonic buffer to release the soluble lysosomal enzymes. The mixtures were then homogenized on ice with a polytron for
a total of 2 min with intervals of 30 s on ice. The homogenates were ultracentrifuged at 100,000 × g for 40 min, and
the supernatant fractions were then subjected to column chromatography
on ConA-Sepharose (Amersham Pharmacia Biotech). The bound fractions
were eluted with 100 mM Western Blotting Analysis of Chromatography Fractions--
25
µl each of the fractions from the ConA and DE52 columns were
subjected to 12.5% SDS-PAGE under reduced conditions as described above. Transferred protein blots were incubated with anti-esterase C12
IgY antibody as the primary antibody, followed by development with a
peroxidase-conjugated donkey anti-chicken IgY secondary antibody
(Bio-Rad) and Supersignal substrate (Pierce).
Assay for the Sialic Acid 9-O-Acetylesterase--
As described
previously (43),
[9-O-acetyl-3H]Neu5,9Ac2 is
prepared by labeling purified rat liver Golgi with
[acetyl-3H]acetyl coenzyme A. The enzyme source (50-100
µl) is incubated with the substrate (10,000 cpm) at 37 °C for
1 h, and the reaction is quenched by the addition of equal volume
of "stopping mixture," followed by mixing with a toluene-based
scintillation mixture. The uncleaved substrate cannot enter the toluene
phase, but free [3H]Acetate (the cleavage product) can,
allowing determination of the activity.
PNGase F Digestion of the Lse/Cse-C Fractions--
Aliquots of
fractions positive for the activity/Western blot signal for the chicken
antibody were incubated with PNGase F for the cleavage of
N-linked oligosaccharides. The digested material was
compared with sham-treated material and analyzed by Western blotting.
Two Different Types of Messages Are Encoded by the Lse
Gene--
During characterization of the cDNA for the lysosomal
Sia 9-O-acetylesterase (Lse) (39), we cloned a novel
cDNA from a pre B cell line library (70Z/3), in which the signal
peptide encoding region of Lse in its 5' region was substituted with a
novel sequence (Fig. 1). Because the
substituted region completely matches exon 1 of the Lse
gene,2 this new message
seemed likely to be derived from an alternate promoter usage. The new
cDNA is missing the original ATG codon of the Lse but has multiple
in-frame ATG codons throughout the substituted 5' region and the common
sequence. Because the consensus sequence for endoplasmic reticulum
targeting (the signal peptide) would be missing from the putative
polypeptide encoded by this cDNA, we considered it a candidate for
the previously described cytosolic Cse activity; this cDNA is
hereafter called the Cse candidate (Cse-C).
Cse-C Codes for a Distinct Protein When Transiently Expressed in
COS7 Cells--
To determine the functional open reading frame of
Cse-C, we created constructs for transient expression of Cse-C and the
original Lse, each with a FLAG epitope tag incorporated into its C
terminus. Anti-FLAG affinity chromatography was used to isolate
epitope-tagged proteins from COS7 cells transiently transfected with
either Lse-FLAG or Cse-C-FLAG. Production of polypeptides were studied
by Western blotting using the anti-FLAG M2 antibody. Most of the Lse
protein was recovered as a secreted form in the medium. This is in
keeping with previous reports that a significant fraction of lysosomal enzymes are secreted into the medium when hyperexpressed in COS cells
(38). In contrast, the Cse-C-FLAG product was mainly recovered in the
cell lysate. Western blotting analysis of the anti-FLAG-Sepharose eluate showed that the secreted Lse was the expected uncleaved single
band in the medium (the apparent molecular mass of 82 kDa is higher
than that of the polypeptide backbone, presumably because of
N-glycosylation and possibly O-glycosylation; see
below). The Cse-C-FLAG product purified from cell lysates showed two
bands of 51.5 and 28 kDa under reducing conditions (Fig.
2A). The smaller 28-kDa band
showed a slower mobility in nonreducing conditions, indicating that the
Cse-C-FLAG product can be cleaved by an endogenous proteinase to form
heteromeric subunits (data not shown). Assuming that the 28-kDa
fragment originated from the 51.5-kDa pro-polypeptide and accounting
for the Kozak sequences (44) required for a functional starting codon
(Fig. 2B), it is likely that the translation machinery in
COS7 cells is using the Met-75 ATG downstream from the N terminus of
the Lse open reading frame to create a protein missing the signal
sequence and some of the N-terminal region (a total of 75 amino acids
is truncated, compared with the mature Lse). The comparison between the
Lse and putative Cse-C sequences is shown in Fig. 1B. The
FLAG epitope-tagged forms of both molecules showed Sia
9-O-acetylesterase activity when affinity purified with
anti-FLAG-Sepharose and assayed (data not shown). However, the Cse-C
activity was rather unstable to routine elution with low pH. We
therefore eluted the beads with a more gentle method, using the FLAG
peptide itself (Fig. 2C). The activity recovered by this
method was also not completely stable, falling by about half during 1 week of storage at 4 °C. In contrast, the Lse-FLAG product showed
activity that was stable to acid elution, as well as prolonged storage
at 4 °C (data not shown). These properties are in keeping with those previously reported for lysosomal and cytosolic Sia
9-O-acetylesterase activities from biological sources (see
"Discussion"). Because of the small amount of the Cse-C-FLAG
product and activity available from the cell lysate and the instability
to storage, more detailed studies of its enzymatic activity were not
pursued.
The Cse-C Form Localizes to the Cytosol of Transiently Transfected
COS7 Cells--
To confirm that the Cse-C encodes a cytosolic protein,
we again transfected COS7 cells with the Lse-FLAG and Cse-C-FLAG
constructs and detected the subcellular localization of the products by
indirect immunofluorescent staining using the anti-FLAG M2 antibody.
Staining of the Lse-FLAG product showed that the portion retained in
the cells indeed gave a punctate pattern consistent with the
lysosome/endosome/Golgi localization expected because of the signal
sequence at the N terminus. In contrast, the Cse-C-FLAG product was
detected diffusely throughout the cytosol with the subcellular
organelles appearing as unstained regions (Fig.
3).
RT-PCR Analysis Indicates that the Two Forms of cDNA Have a
Different Profile of Message Expression in Normal Mouse
Tissues--
Previously reported Northern blot analyses would not have
distinguished between the expression of the two forms of esterase message in normal tissues. To examine the relative expression of the
two forms in different tissues, we used sets of primers to selectively
amplify the distinct 5' sequences of Lse and Cse-C. This RT-PCR
analysis shows that the expression of the two forms are quite different
in various tissues of the mouse. Lse showed a widespread expression
(Fig. 4A), suggesting that
this message is derived from a general expression type of promoter. In
contrast, the Cse-C showed rather tissue-specific expression with the
strongest signal found in the brain and ovary and some detectable
signal in the liver and thymus (Fig. 4B). Interestingly,
multiple bands were sometimes observed from the Cse-C amplification,
which were especially strong in the brain. Some of the major bands
appearing in Cse-C amplification were directly sequenced. This analysis showed that only liver has the exact sequence expected from 7A3-C clone
and that there can be multiple populations of 5' noncoding sequences
attached to the beginning of universal Lse exon 2 (Fig. 4B).
In other tissues, the dominant signal amplified has truncated 7A3-C
sequence and corresponds to the 7A3-D clone shown in 5'-rapid amplification of cDNA ends rapid amplification of cDNA ends
studies from the 70Z/3 cell line (39). This indicates that alternative splicing events are occurring in the processing of this message. However, none of the other form sequences have an alternative open
reading frame to code any new type of translational product. Thus,
despite the multiple 5' variations found in the new cDNAs, the
protein coded by all these messages is expected to be the same. It is
of course possible that these different 5' noncoding regions may affect
the efficiency of translation and/or alter the stability of the
message. Also, because we found variable types of message in the brain,
there remains a possibility of other as yet unidentified type of
messages derived from independent promoters and/or splicing that might
not be detected by this RT-PCR experiment.
A Chicken IgY Directed against the Esterase C Terminus--
We had
previously reported that a rabbit polyclonal antibody that reacted with
rat liver Lse did not cross-react with Cse activity in the same tissue.
However, this antibody was produced by a single rabbit out of many that
failed to respond. We assume that this difficulty in raising a
mammalian antibody response against the intact Lse protein is because
of a high degree of conservation of the protein. We therefore raised
polyclonal antibodies in chickens, directed against a 69-amino acid
region that is common to the Lse and the Cse protein (Fig.
1B, amino acids 381-450). This C-terminal peptide was
expressed in a bacterial system as a maltose-binding fusion protein,
purified as described, and used to immunize chickens. The IgY was
purified from egg yolk and studied for reaction by Western blot
analysis with the recombinant intact Lse or with freeze-thaw
extracts of tissues. One of the positive chicken antibodies (C-12) was
found to specifically detect bands in a similar pattern in both mouse
and rat tissues using the freeze-thaw supernatant fraction that is
known to have both the Lse and Cse activities (data not shown; no bands
were seen with control chicken IgY preparations under the same
conditions of staining).
Cse-C Polypeptides Correspond to Major Activity for Cytosolic
Sialic Acid 9-O-Acetylesterase in Buffer-extracted Mouse
Liver--
Lse and Cse from the rat liver were previously reported as
9-O-acetylesterase activities that bound to ConA or DEAE,
respectively (36). To correlate these activities with the Lse
gene-derived polypeptides reactive with the chicken antibody, we
studied mouse liver. The tissue was homogenized in the buffer with a
Polytron after two freeze-thaw cycles, and the homogenates were then
ultracentrifuged to collect a fraction that should contain both the Cse
and the Lse (the latter being released from disrupted lysosomes). The extracts were first applied to the ConA-Sepharose column and eluted with
As shown in Fig. 5A, Western
blotting with this antibody indeed gave the expected signal for the Lse
polypeptide in the ConA-eluted fraction of the liver extract (~82
kDa). However, Sia 9-O-acetylesterase activity was not
easily detectable in these fractions, probably because of the much
lesser extent of Lse expression in mouse liver when compared with rat
liver (from where we originally purified the enzyme). This is also
consistent with the observation in transfected COS7 cells that Western
blotting gave a much higher sensitivity than
9-O-acetylesterase activity assay. We therefore carried out a similar study on rat liver extracts, where the Lse forms a much higher proportion of total 9-O-acetylesterase activity (36). Indeed, as expected we found that the ConA eluted fractions from rat
liver extracts contained a similar ~82-kDa band that coincided with
the esterase activity assay (data not shown).
The ConA run-through fractions from the mouse liver extract
contained esterase activity which was maximal in sample tube 4 rather
than in the peak sample tube 2. This is possibly because of nonspecific
inhibition by the large amount of extract protein in fraction 2 (this
may also account for the large number of nonspecific bands in the
Western blot of this fraction, which did not persist in the following
step). A pool of the ConA run-through (sample tubes 1-4) was applied
to a DEAE column, which was eluted with increasing concentrations of
NaCl. The major peak of esterase activity coincided with the elution of
single 57-kDa band on Western blotting (Fig. 5B). Because
the FLAG epitope-tagged protein studied above showed weak but
detectable activity and encoded a protein expressed in the cytosol, it
is likely that the 57-kDa polypeptide is responsible for the
buffer-extracted Cse activity in mouse liver. The minor difference in
the size may be caused by an unknown protein modification of the
cytosolic protein. Alternatively, a different ATG start codon might be
used in mouse liver than in COS cells.
Polypeptides derived from the Lse message (with a signal peptide
encoding sequence) are expected to carry N-glycans, whereas those derived from the Cse-C message (or others without a signal peptide encoding sequence) should not. To examine this issue, we
studied the fractions obtained above by Western blotting following PNGase F digestion to release N-glycans (Fig.
6). As predicted, PNGase F treatment of
the ConA-eluted Lse band caused a shift of the ConA eluted 82-kDa band
to 72 kDa (because the expected size of the Core polypeptide is 61 kDa,
this suggests the presence of other modifications, such as
O-glycosylation). In contrast to the result with the ConA
bound fraction, there was no effect of PNGase F on the putative Cse-C
products (DE52 eluted fraction, Fig. 6). This further confirms that
Cse-C-related message products are indeed cytosolic proteins without
N-glycosylation.
Based on the data in this study, we propose that a single Sia
9-O-acetylesterase gene can encode two differently localized proteins by differential usage of the signal peptide encoding exon
found at the N terminus. To date, there are relatively few such
examples wherein a single gene can produce polypeptides targetted to
different cell compartments (45). This was first demonstrated in the
yeast invertase (SUC2) gene (46, 47). A mammalian gene for the
actin-modulating protein Gelsolin uses an alternative promoter to
derive plasma and cytosolic forms message with and without signal
peptide sequence, respectively (48). Recently, interleukin-15 was also
shown to target to different compartments. In this case, the
interleukin-15 gene encodes two different transcripts with or without
the full-length signal sequence peptide by means of alternative
splicing, and the products with the incomplete signal sequences were
shown to be targetted to the cytosol instead of being secreted out from
the cells (49). However, in all examples, the functional relevance of
the "alternative form" are unknown (i.e. cytosolic
invertase, plasma form of Gelsolin, cytosolic form of interleukin-15 in
cytosol). In the case of the Sia 9-O-acetylesterase gene,
both the Lse and Cse have potential substrates in their respective
locations. Moreover, Lse has an additional localization signal for
targetting to the lysosome, apparently using mannose 6-phosphorylation.3
The only difference between the two messages is in the 5' terminus, and
the 5'-rapid amplification of cDNA ends product of the Lse-type
message did not show any additional sequences in its 5' region. Taken
together with the differences in tissue-specific expression, it seems
likely that the Lse and Cse use different promoters for their
expression. In this regard, we do have some information concerning the
genomic organization of exon 1 of Lse and exon 2 of both forms. We know
that in between these exons, there is no exon for Cse detected by
Southern hybridization.2 Thus, the Cse promoter and
transcription initiation site must be somewhere in the more 5' region
of the esterase gene, upstream of the first Lse exon, which encodes its
signal peptide. To definitively prove differential promoter usage and
to completely rule out any unusual form of alternative splicing, we
need to clone and characterize the entire genomic organization of the
esterase gene, together with a complete promoter analysis.
Using Western blot analysis with an antibody against the common C
terminus, we were able to differentiate the activity of the Lse and Cse
forms, because the two proteins behaved in a distinct way by column
chromatography. In retrospect, characterization of the two enzymes had
already shown some shared features other than the fact that both have a
common substrate, 9-O-acetyl Sia. Both activities are
inhibited by diisopropyl fluorophosphate treatment, suggesting a
serine-active site in each. The two activities also have a neutral pH
optimum (32, 34, 36). In regard to the last point, it is notable that
Lse was shown to co-localize with conventional "acid hydrolases" by
an EM study (34). This suggests that the Lse-catalyzed reaction may
takes place in the early endosome where the pH of the compartment is
closer to neutral. Because lysosomal degradation of the
oligosaccharides takes place from the outer terminii, it could be that
the enzymes cleaving these act in advance of the other exoglycosidases,
whereas the pH of the compartment is still not too acidic, making
lysosomal hydrolysis more efficient. An alternate possibility we had
suggested earlier is that the pH of lysosomes might not always be
acidic but rather fluctuates between neutral and acidic states
(34).
In contrast to the Lse, the Cse has been proposed as a "recycling"
enzyme acting on the free cytosolic pool of 9-O-acetylated Sia. Because O-acetylated forms of Sia are poor substrates
for CMP-NeuAc synthase, for some of the sialyltransferases, and for acylneuraminic acid pyruvate lyase, the presence of Cse would assure a
higher efficiency in the recycling of Sias. In this regard it is
interesting that the Cse activity is very high in the brain, where
9-O-acetylated Sias are commonly expressed. Of course, for this model to work, other Sia-recognizing proteins such as the lysosomal sialidases and the lysosomal Sia exporter should not be too
sensitive to the presence of O-acetyl groups. This matter has not yet been explored.
The substrate specificities for the Lse and Cse might also be subtly
different. Purified rat liver Lse was shown to cleave O-acetyl groups only from the 9-position of Sias (36). In
contrast, Schauer and colleagues (32) reported that a bovine brain Cse showed activity toward the 4-O-acetylated Sia as well.
Because their bovine Cse was not purified to homogeneity, it is not
possible to be certain that the latter activity was derived from the
same polypeptide. However, it is interesting to speculate that a Cse lacking the N terminus might have relaxed substrate specificity relative to the Lse by assuming that brain Cse is also coded by the
Cse-C form of this gene.
The recombinant Cse-C needed to be exposed to low pH for a brief moment
during acid elution from the anti-FLAG resin, and this may account for
the lower recovery of activity compared with that obtained with the
more expensive method, elution using the FLAG peptide. Even with the
latter elution method, the purified material lost activity during
further storage. This finding is actually in keeping with previous
observations that naturally occurring Cse is not a stable enzyme (in
contrast to Lse, which is very stable both in vivo and
in vitro). It is noteworthy that Cse-C lacks a single
cysteine residue in its primary amino acid sequence compared with Lse.
This can be another explanation for the difference in its stability.
Using COS7 cell transfection experiments, we could not obtain enough
recombinant Cse protein to examine all the details of its activity.
Ultimately, purification, characterization, and crystallization of
those two enzymes in the presence of the various substrates will be
required to fully compare their activities.
For Lse, it was previously suggested that a naturally occurring
lysosomal cleavage of this polypeptide might expose the activity (33).
However, we found the active nonclipped form both in the medium of
transiently transfected COS7 and in a rat liver extract. Thus, it is
fair to conclude that the cleavage of the Lse is not essential for
exposing the activity (although we cannot rule out a further increase
in activity upon cleavage). We found two bands of Cse signals in the
COS7 transfection experiment. Because we did not detect 28-kDa signal
in the mouse liver, it is likely that the 28-kDa fragment represents
proteolytic cleaved material derived from the 51-kDa fragment. But it
has not yet been possible to identify which form is active in the COS7
cells. Since the 28-kDa band is dramatically reduced in amount in the
Western blot under nonreducing conditions, it is likely that it is
associated with an N-terminal subunit through an S-S bond as also found
in Lse, even though the precise site of cleavage appears to be
different. This can be explained by the fact that the two proteins are
processed in different cell compartments.
In the mouse liver, we were not able to recover activity of the Lse,
even though the Lse message is strongly expressed in the RT-PCR
experiment, and an immunoreactive polypeptide was detectable. This
suggests the possibility that, as in the COS cells, the bulk of mouse
liver Lse might be secreted. This may also explain why our initial
attempt to produce antibodies against purified rat Lse in rabbits was
not very successful (33). The only one among many immunized rabbit sera
that showed anti-Lse activity had an inhibitory effect for the Lse
activity but not for Cse. This is probably because that particular
polyclonal antibody was directed against a very limited epitope that
was unique for Lse. We used a chicken for immunization to raise an
antibody because genomic Southern blot cross-hybridization of mouse
full-length Lse cDNA was a lot weaker with chicken genomic DNA
compared with DNA from mammalian species.2 The availability
of this antibody reactive to primary amino acid sequence made it
possible for us to study the translated polypeptides of both messages
after using ConA and DEAE columns to physically separate them. Of
course, although it is very likely that the Cse-C is encoding the
cytosolic activity found in the mouse liver, it remains possible that
the antibody is cross-reacting with a product from a closely related
gene. The other unlikely possibility is proteolytic cleavage of the Lse
followed by de-N-glycosylation and export to the cytosol
(such proteins are normally rapidly degraded by proteasomes).
PNGase F digestions confirmed that only the ConA binding Lse band not
the Cse-C band carries N-glycans, further supporting the
cytosolic location of the latter. In contrast to the extensive cleavage
of the Cse (51-28 kDa) that we saw in COS cells, buffer-extracted Cse
activity in mouse liver coincided primarily with the of 57-kDa polypeptide without cleaved material. The difference in size of the
COS7-derived band (51 kDa) and that from the mouse liver (57 kDa) might
indicate an unknown post-translational modification of this enzyme in
different tissues/systems, because we used the "liver form" clone
for the transient COS7 expression experiment. Alternatively, since
there are multiple in-frame ATG codons throughout this cDNA (Fig.
2B), it is possible that these two cell types are using a
different start codon for translational initiation.
From these data we conclude that at least some portion of the
previously reported Cse activity can be explained by the alternate cytosolic form derived from the Lse gene. However, our ongoing studies
(data not shown) suggest that in tissues other than liver (e.g. brain), there are some cytosolic
9-O-acetylesterase activity peaks that do not coincide with
the immunoreactive bands. Thus, it is probable that there are one or
more other genes that can generate Cse activity in other tissues.
Furthermore, when mouse liver was extracted in the presence of
detergent (0.1% Triton X-100), additional immunoreactive bands were
detected that did not coincide with peaks of Sia
9-O-acetylesterase activity (data not shown). It is apparent
that there are even greater complexities in the forms of message and
polypeptide that can be derived from the Lse gene. Further studies are
needed to sort out all these complexities.
With regard to the presence of a Cse-like activity previously reported
in red blood cells (50), the significance is not really clear, because
there should be no turnover of Sias in these cells. It is possible that
this Cse has an alternative role in such cells or that it is left over
from the earlier phase of red cell development. Even though the
molecular mechanisms and topology are not easy to explain, it is
noteworthy that expression of a cytosolic sialidase resulted in a
reduced amount of intercellular GM3 expression and
increased amounts of its hydrolyzed product lactosyl ceramide in stably
transfected B16 melanoma cells (51) and epidermoid carcinoma cells
(52). If a similar situation applies for O-acetylated
gangliosides, it is possible that this cytosolic enzyme can still
regulate O-acetylated ganglioside expression in certain cell types.
Expression of the O-acetylation on Sia is regulated in
temporal and spatial patterns during the embryogenesis and
organogenesis (2). This modification is also known to be selectively
expressed on certain underlying sialoconjugate epitopes (30). These
studies imply that this modification is playing a role in the specific cell-cell recognition events during the developmental process. To study
the mechanism and significance of regulation of Sia
O-acetylation in the biological systems, information
regarding all the metabolizing steps is essential. In the present
study, we report the cDNA cloning and the regulation of
biosynthetic mechanism of lysosomal and cytosolic forms of
O-acetylation hydrolyzing enzymes. Further studies should be
pursued to examine how these factors are affecting a given cell systems
through the hydrolysis of O-acetyl groups on Sias.
Ultimately, to assign a definitive function, the
O-acetylation profile and phenotype resulting from in
vivo genetic disruption of the Cse and Lse activities needs to be studied.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-minimum essential medium with 20% fetal calf serum
was added to a final of 10%, followed by an overnight incubation in
-minimum essential medium.
-D-galactoside at 37 °C for 3 h. Secreted
fusion protein was directly purified from the medium by passage through
a maltose column. The purity of the purified protein was confirmed by
Coomassie Brilliant Blue staining after SDS-PAGE. The purified protein
was used to immunize Rhode Island Red female chickens four times over a
period of 2 months. After 2 months from the initial immunization,
nonfertile eggs were collected, and the IgY was purified from egg yolk
by using the Promega Eggstract kit.
-methylmannopyranoside in 20 mM KPO4 pH 8, 0.1 M NaCl. ConA
run-through fractions positive for Sia 9-O-acetylesterase activity (see assay described below) were pooled, dialyzed against 20 mM KPO4 pH 8, and loaded onto a DE52
(DEAE-cellulose) column (Whatman). After washing, the bound proteins
were eluted with 15 ml of 150-400 mM NaCl gradient,
followed by 5 ml of 400 mM NaCl (36).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (73K):
[in a new window]
Fig. 1.
Differing sequences at the 5' ends of
cDNAs derived from the Lse gene. A, schematic of
the cDNA structures of the Lse and the putative Cse clones.
Noncoding regions of Lse cDNA are indicated by black
lines. The previously reported Lse enzyme purified from rat liver
(36) was a heterodimer of two polypeptides as depicted by the
differently patterned boxes. Proteolytic cleavage takes
place to a variable extent between the differently patterned
boxes during Lse maturation in the endosomes/lysosomes. The
white box in Cse-C indicates the sequence that replaces the Lse exon 1. The Cse-C message is expected to encode a single
polypeptide. B, primary sequences and proposed open reading
frames of the 5' ends of the Lse and the putative Cse (7A3-C clone).
The translational initiation of Cse-C sequence is depicted here as
starting at Met75 (see Fig. 2 for other possibilities). The
underlined nucleotide sequence shows the Cse-C specific 5'
sequence. Underlined peptide sequences indicate the
polypeptide residues used for immunization of chickens for IgY
preparation. Arrows in the Lse amino acid sequence indicate
the N termini of the small and large subunit, respectively.

View larger version (38K):
[in a new window]
Fig. 2.
Epitope-tagged products of the Lse and Cse-C
cDNAs expressed in COS cells. A, Western blot of
affinity purified Lse and Cse-C from transfected COS7 cells. Lse-FLAG
(L) was purified from the culture medium and Cse-C-FLAG
(C) from cell lysates of transfected COS7 cells as described
under "Experimental Procedures." The Cse-C-FLAG construct contains
the exact sequences shown in Fig. 1B. Purified proteins are
subjected to SDS-PAGE under reducing conditions and detected by
immunoblot with an anti-FLAG antibody after transfer to a
nitrocellulose membrane. The molecular masses of bands are indicated by
the arrows. The relative amounts of the 51.5- and 28-kDa
bands varied in different preparations. B, Kozak concensus
sequences of putative start sites in the Cse-C construct, matched
together with expected molecular masses. The consensus sequence for
translational initiation is shown above. The chart lists the
positions of potential initiation codon (Met residue), the type of the
cDNA where the potential ATG codons exist (cDNA), putative
molecular mass of each translation product, and matching numbers to the
Kozak sequence in position
3 and +4 residues of each ATG codon (44).
The most likely start codon is at Met75, which is the only
one that shares the two most conserved residues of the Kozak sequence
and fits the molecular mass of the product found in the COS7 cells.
C, COS7 cells were transfected with Cse-C-FLAG vector and
cell lysates incubated with M2 anti-FLAG affinity gel as described
under "Experimental Procedures." The gel was then packed into a
column and eluted stepwise with increasing concentration of the FLAG
peptide in Tris-buffered saline. 50-µl aliquots of each fraction was
assayed for 9-O-acetylesterase activity with
[9-O-acetyl-3H]Neu5,9Ac2 as
described under "Experimental Procedures." n.d.
indicates that the activity was not detected.

View larger version (26K):
[in a new window]
Fig. 3.
Indirect immunofluorescence staining of
transfected COS cells. COS7 cells were transiently transfected
with Lse-FLAG (L) or Cse-C-FLAG (C) constructs.
Subcellular localization was identified by immunofluorescent staining
using a monoclonal antibody against the FLAG epitope tag as described
under "Experimental Procedures." The Lse construct gives mainly a
perinuclear Golgi staining pattern, along with punctate staining
typical of lysosomes and endosomes. In contrast, the Cse-C construct
gave a widespread diffuse staining pattern localized to the
cytosol.

View larger version (28K):
[in a new window]
Fig. 4.
RT-PCR analysis of expression of Lse and
Cse-C messages in mouse tissues. As described under
"Experimental Procedures," the RT-PCR method was applied using
primers specific for the 5' ends of the Lse (A) and Cse-C
(B) messages. Total cellular RNA was purified from various
mouse tissues including liver (L), brain (B),
kidney (K), thymus (TH), spleen (S),
testis (TE), ovary (O), and skeletal muscle
(SM). First strand cDNA derived from each source was
subjected to PCR by the primer set, which only amplifies each form of
message. PCR products were detected by ethidium bromide staining after
1.2% agarose gel electrophoresis. The sizes of Lse bands were 810 bp
as expected in contrast to the Cse-C that the expected size is 890 bp,
which appeared only in the liver. In other tissue, Cse-C gave 777 bp
amplification, which is the size of alternate Cse-C type clone
originally identified as clone 7A3-D (39) in 5'-rapid amplification of
cDNA ends experiment in 70Z/3 cell line. For the ovary sample shown
in panel B, one-fifth of the template amount was used.
-methyl-mannoside (Lse activity should bind to the column and
be eluted). The flow-through fraction from ConA-Sepharose was then
applied to the DEAE-cellulose column and then eluted with a NaCl
gradient (Cse should bind and be eluted). Column fractions were assayed
for Sia 9-O-acetylesterase activity and also studied by
Western blotting using the C-12 Chicken IgY directed against the shared
69-amino acid region of both enzymes.

View larger version (16K):
[in a new window]
Fig. 5.
Western blot and activity analysis of
chromatography fractions from mouse liver extract. Freshly
obtained mouse liver was extracted as described under under
"Experimental Procedures" and subjected first to ConA-Sepharose
affinity chromatography. The run-through fraction from the ConA column
was then applied to a DEAE-cellulose (DE52) column that was washed and
eluted with a linear gradient of NaCl, as described under
"Experimental Procedures." Aliquots from the fractions were assayed
for Sia 9-O-acetylesterase activity ([3H]acetate release)
or by SDS-PAGE under reducing conditions, followed by Western blotting
with the chicken IgY antibody directed against a 69-amino acid sequence
shared by the Lse and Cse-C cDNAs. Molecular mass standard markers
are shown to the right, and major signal size are shown to
the left of the blot.

View larger version (18K):
[in a new window]
Fig. 6.
Western blotting analysis of PNGase
F-digested Lse and Cse-C fractions. Aliquots of fractions obtained
in the experiment shown in Fig. 5 (sample tube 8 from the ConA elution
and 17 from the DEAE elution) were treated or sham-treated with PNGase
F to remove N-glycans, then subjected to SDS-PAGE under
reducing conditions, and Western blotted with the chicken IgY antibody
directed against a 69-amino acid sequence shared by the Lse and Cse-C
cDNAs. Molecular mass standard markers are shown to the
right of the blot.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Nissi Varki for help with immunofluorescent staining of the COS7 cells and Dr. Lubor Borsig for critical discussions throughout this study.
| |
FOOTNOTES |
|---|
* This work was supported by Grants HL57345 and GM32373 from the U. S. Public Health Service (to A. V.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF156856.
¶ To whom correspondence should be addressed: Cancer Center, 0687, UCSD School of Medicine, La Jolla, CA 92093-0687. Tel.: 619-534-3296; Fax: 619-534-5611.
2 H. Takematsu and A. Varki, unpublished data.
3 S. Diaz and A. Varki, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: Sia, sialic acid; Cse, cytosolic sialic acid 9-O-acetylesterase; Lse, lysosomal sialic acid-specific 9-O-acetylesterase; RT, reverse transcription; PCR, polymerase chain reaction; ConA, Concanavalin A; bp, base pair(s); PAGE, polyacrylamide gel electrophoresis; PNGase F, peptide N-glycosidase F.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Schauer, R. (1982) Sialic Acids: Chemistry, Metabolism and Function, Cell Biology Monographs , Vol. 10 , Springer-Verlag, New York |
| 2. |
Varki, A.
(1992)
Glycobiology
2,
25-40 |
| 3. | Varki, A. (1997) FASEB J. 11, 248-255[Abstract] |
| 4. |
Kansas, G. S.
(1996)
Blood
88,
3259-3287 |
| 5. | McEver, R. P., and Cummings, R. D. (1997) J. Clin. Invest. 100, 485-492[Medline] [Order article via Infotrieve] |
| 6. | Varki, A. (1997) J. Clin. Invest. 99, 158-162[Medline] [Order article via Infotrieve] |
| 7. | Crocker, P. R., Clark, E. A., Filbin, M., Gordon, S., Jones, Y., Kehrl, J. H., Kelm, S., Le Douarin, N., Powell, L., Roder, J., Schnaar, R. L., Sgroi, D. C., Stamenkovic, K., Schauer, R., Schachner, M., Van den Berg, T. K., Van der Merwe, P. A., Watt, S. M., and Varki, A. (1998) Glycobiology 8, v |
| 8. |
Powell, L. D.,
and Varki, A.
(1995)
J. Biol. Chem.
270,
14243-14246 |
| 9. | Kelm, S., and Schauer, R. (1997) Int. Rev. Cytol. 175, 137-240[Medline] [Order article via Infotrieve] |
| 10. |
Cornish, A. L.,
Freeman, S.,
Forbes, G.,
Ni, J.,
Zhang, M.,
Cepeda, M.,
Gentz, R.,
Augustus, M.,
Carter, K. C.,
and Crocker, P. R.
(1998)
Blood
92,
2123-2132 |
| 11. | Herrler, G., Rott, R., Klenk, H. D., Muller, H. P., Shukla, A. K., and Schauer, R. (1985) EMBO J. 4, 1503-1506[Medline] [Order article via Infotrieve] |
| 12. | Miller-Podraza, H., Abul Milh, M., Teneberg, S., and Karlsson, K. A. (1997) Infect. Immun. 65, 2480-2482[Abstract] |
| 13. | Miller-Podraza, H., Bergstrom, J., Milh, M. A., and Karlsson, K. A. (1997) Glycoconj. J. 14, 467-471[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Johansson, L., and Karlsson, K. A. (1998) Glycoconj. J. 15, 713-721[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Schauer, R. (1970) Hoppe. Seylers. Z. Physiol. Chem. 351, 749-758[Medline] [Order article via Infotrieve] |
| 16. | Schauer, R., and Wember, M. (1971) Hoppe-Seyler's Z. Physiol. Chem. 352, 1282-1290[Medline] [Order article via Infotrieve] |
| 17. | Schlosshauer, B., Blum, A. S., Mendez Otero, R., Barnstable, C. J., and Constantine-Paton, M. (1988) J. Neurosci. 8, 580-592[Abstract] |
| 18. | Sparrow, J. R., and Barnstable, C. J. (1988) J. Neurosci. 21, 398-409 |
| 19. |
Blum, A. S.,
and Barnstable, C. J.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
8716-8720 |
| 20. |
Sjoberg, E. R.,
Powell, L. D.,
Klein, A.,
and Varki, A.
(1994)
J. Cell Biol.
126,
549-562 |
| 21. |
Collins, B. E.,
Yang, L. J. S.,
Mukhopadhyay, G.,
Filbin, M. T.,
Kiso, M.,
Hasegawa, A.,
and Schnaar, R. L.
(1997)
J. Biol. Chem.
272,
1248-1255 |
| 22. |
Collins, B. E.,
Kiso, M.,
Hasegawa, A.,
Tropak, M. B.,
Roder, J. C.,
Crocker, P. R.,
and Schnaar, R. L.
(1997)
J. Biol. Chem.
272,
16889-16895 |
| 23. | Kelm, S., Brossmer, R., Isecke, R., Gross, H. J., Strenge, K., and Schauer, R. (1998) Eur. J. Biochem. 255, 663-672[Medline] [Order article via Infotrieve] |
| 24. | Strenge, K., Schauer, R., Bovin, N., Hasegawa, A., Ishida, H., Kiso, M., and Kelm, S. (1998) Eur. J. Biochem. 258, 677-685[Medline] [Order article via Infotrieve] |
| 25. |
Shi, W. X.,
Chammas, R.,
Varki, N. M.,
Powell, L.,
and Varki, A.
(1996)
J. Biol. Chem.
271,
31526-31532 |
| 26. |
Muchmore, E.,
and Varki, A.
(1987)
Science
236,
1293-1295 |
| 27. | Varki, A., Hooshmand, F., Diaz, S., Varki, N. M., and Hedrick, S. M. (1991) Cell 65, 65-74[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Diaz, S.,
Higa, H. H.,
Hayes, B. K.,
and Varki, A.
(1989)
J. Biol. Chem.
264,
19416-19426 |
| 29. | Chammas, R., McCaffery, J. M., Klein, A., Ito, Y., Saucan, L., Palade, G., Farquhar, M. G., and Varki, A. (1996) Mol. Biol. Cell 7, 1691-1707[Abstract] |
| 30. |
Shi, W. X.,
Chammas, R.,
and Varki, A.
(1996)
J. Biol. Chem.
271,
15130-15138 |
| 31. |
Higa, H. H.,
Butor, C.,
Diaz, S.,
and Varki, A.
(1989)
J. Biol. Chem.
264,
19427-19434 |
| 32. |
Schauer, R.,
Reuter, G.,
Stoll, S.,
and Shukla, A. K.
(1989)
J. Biochem. (Tokyo)
106,
143-150 |
| 33. |
Butor, C.,
Higa, H. H.,
and Varki, A.
(1993)
J. Biol. Chem.
268,
10207-10213 |
| 34. | Butor, C., Griffiths, G., Aronson, N. N., Jr., and Varki, A. (1995) J. Cell Sci. 108, 2213-2219[Abstract] |
| 35. |
Higa, H. H.,
and Paulson, J. C.
(1985)
J. Biol. Chem.
260,
8838-8849 |
| 36. |
Higa, H. H.,
Manzi, A.,
and Varki, A.
(1989)
J. Biol. Chem.
264,
19435-19442 |
| 37. | Schauer, R. (1988) Methods Enzymol. 138, 611-626 |
| 38. |
Guimaraes, M. J.,
Bazan, J. F.,
Castagnola, J.,
Diaz, S.,
Copeland, N. G.,
Gilbert, D. J.,
Jenkins, N. A.,
Varki, A.,
and Zlotnik, A.
(1996)
J. Biol. Chem.
271,
13697-13705 |
| 39. |
Stoddart, A.,
Zhang, Y.,
and Paige, C. J.
(1996)
Nucleic Acids Res.
24,
4003-4008 |
| 40. | Authors. (1993) Current Protocols in Molecular Biology , Greene Publishing and Wiley-Interscience, New-York |
| 41. | Coligan, J. E. (1996) Current Protocols in Protein Science , John Wiley & Sons, Inc., Brooklyn, NY |
| 42. | Sambrook, J., Maniatis, T., and Fritsch, E. F. (1989) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 43. | Higa, H. H., Manzi, A., Diaz, S., and Varki, A. (1989) Methods Enzymol. 179, 409-415[Medline] [Order article via Infotrieve] |
| 44. |
Kozak, M.
(1991)
J. Cell Biol.
115,
887-903 |
| 45. | Danpure, C. J. (1995) Trends Cell Biol. 5, 230-238 [CrossRef][Medline] [Order article via Infotrieve] |
| 46. | Carlson, M., and Botstein, D. (1982) Cell 28, 145-154[CrossRef][Medline] [Order article via Infotrieve] |
| 47. |
Carlson, M.,
Taussig, R.,
Kustu, S.,
and Botstein, D.
(1983)
Mol. Cell. Biol.
3,
439-447 |
| 48. |
Kwiatkowski, D. J.,
Mehl, R.,
and Yin, H. L.
(1988)
J. Cell Biol.
106,
375-384 |
| 49. |
Tagaya, Y.,
Kurys, G.,
Thies, T. A.,
Losi, J. M.,
Azimi, N.,
Hanover, J. A.,
Bamford, R. N.,
and Waldmann, T. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14444-14449 |
| 50. |
Varki, A.,
Muchmore, E.,
and Diaz, S.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
882-886 |
| 51. | Tokuyama, S., Moriya, S., Taniguchi, S., Yasui, A., Miyazaki, J., Orikasa, S., and Miyagi, T. (1997) Int. J. Cancer 73, 410-415[CrossRef][Medline] [Order article via Infotrieve] |
| 52. |
Meuillet, E. J.,
Kroes, R.,
Yamamoto, H.,
Warner, T. G.,
Ferrari, J.,
Mania-Farnell, B.,
George, D.,
Rebbaa, A.,
Moskal, J. R.,
and Bremer, E. G.
(1999)
Cancer Res.
59,
234-240 |
This article has been cited by other articles:
![]() |
Y. Naito, H. Takematsu, S. Koyama, S. Miyake, H. Yamamoto, R. Fujinawa, M. Sugai, Y. Okuno, G. Tsujimoto, T. Yamaji, et al. Germinal Center Marker GL7 Probes Activation-Dependent Repression of N-Glycolylneuraminic Acid, a Sialic Acid Species Involved in the Negative Modulation of B-Cell Activation Mol. Cell. Biol., April 15, 2007; 27(8): 3008 - 3022. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tribl, M. Gerlach, K. Marcus, E. Asan, T. Tatschner, T. Arzberger, H. E. Meyer, G. Bringmann, and P. Riederer "Subcellular Proteomics" of Neuromelanin Granules Isolated from the Human Brain Mol. Cell. Proteomics, July 1, 2005; 4(7): 945 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Malisan, L. Franchi, B. Tomassini, N. Ventura, I. Condo, M. R. Rippo, A. Rufini, L. Liberati, C. Nachtigall, B. Kniep, et al. Acetylation Suppresses the Proapoptotic Activity of GD3 Ganglioside J. Exp. Med., December 16, 2002; 196(12): 1535 - 1541. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||